The challenges and opportunities in ovarian cancer relapse—the role of second and third-line chemotherapy: literature review
Gynecology and Pelvic Medicine · 2022-06 · 5 · 15-15
DOI: 10.21037/gpm-21-29 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gynecology and Pelvic Medicine, 2022-06. Verfasst von Semini Greening und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Greening, S., Sood, N., & Nicum, S. (2022). The challenges and opportunities in ovarian cancer relapse—the role of second and third-line chemotherapy: literature review. Gynecology and Pelvic Medicine, 5, 15-15. https://doi.org/10.21037/gpm-21-29
Vancouver
Greening S, Sood N, Nicum S. The challenges and opportunities in ovarian cancer relapse—the role of second and third-line chemotherapy: literature review. Gynecology and Pelvic Medicine. 2022;5:15-15. doi:10.21037/gpm-21-29
BibTeX
@article{Greening2022,
author = {Greening, Semini and Sood, Nikita and Nicum, Shibani},
title = {The challenges and opportunities in ovarian cancer relapse—the role of second and third-line chemotherapy: literature review},
journal = {Gynecology and Pelvic Medicine},
year = {2022},
volume = {5},
pages = {15--15},
doi = {10.21037/gpm-21-29}
}
EUVIMED